CL2011000784A1 - Compuestos derivados de 7-h-pirazoli[3,4-e]-diasepina-6(5h)-ona sustituidos; procedimiento de preparacion; composicion farmaceutica, utiles como agentes antibacteriales. - Google Patents

Compuestos derivados de 7-h-pirazoli[3,4-e]-diasepina-6(5h)-ona sustituidos; procedimiento de preparacion; composicion farmaceutica, utiles como agentes antibacteriales.

Info

Publication number
CL2011000784A1
CL2011000784A1 CL2011000784A CL2011000784A CL2011000784A1 CL 2011000784 A1 CL2011000784 A1 CL 2011000784A1 CL 2011000784 A CL2011000784 A CL 2011000784A CL 2011000784 A CL2011000784 A CL 2011000784A CL 2011000784 A1 CL2011000784 A1 CL 2011000784A1
Authority
CL
Chile
Prior art keywords
pharmaceutical composition
diasepine
pyrazoli
substituted
useful
Prior art date
Application number
CL2011000784A
Other languages
English (en)
Inventor
Ledoussal Benoit
Gourdel Marie-Edith
Renaud Emilie
Camilepierres
Kebsi Adel
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40530144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000784(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novexel filed Critical Novexel
Publication of CL2011000784A1 publication Critical patent/CL2011000784A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Compuestos heterocíclicos nitrogenados derivados de tiadiazoles; procedimiento de preparación de los compuestos; composición farmacéutica que los comprende; y uso de los compuestos como antibacterianos.
CL2011000784A 2008-10-10 2011-04-08 Compuestos derivados de 7-h-pirazoli[3,4-e]-diasepina-6(5h)-ona sustituidos; procedimiento de preparacion; composicion farmaceutica, utiles como agentes antibacteriales. CL2011000784A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0805602A FR2937034B1 (fr) 2008-10-10 2008-10-10 Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens

Publications (1)

Publication Number Publication Date
CL2011000784A1 true CL2011000784A1 (es) 2011-10-07

Family

ID=40530144

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000784A CL2011000784A1 (es) 2008-10-10 2011-04-08 Compuestos derivados de 7-h-pirazoli[3,4-e]-diasepina-6(5h)-ona sustituidos; procedimiento de preparacion; composicion farmaceutica, utiles como agentes antibacteriales.

Country Status (19)

Country Link
US (1) US8148366B2 (es)
EP (2) EP2358722A1 (es)
JP (1) JP2012505195A (es)
KR (1) KR20110067140A (es)
CN (1) CN102216307B (es)
AU (1) AU2009302149A1 (es)
BR (1) BRPI0919807A2 (es)
CA (1) CA2739776A1 (es)
CL (1) CL2011000784A1 (es)
CO (1) CO6382121A2 (es)
EA (1) EA201170546A1 (es)
EC (1) ECSP11010962A (es)
FR (1) FR2937034B1 (es)
IL (1) IL212179A0 (es)
MX (1) MX2011003811A (es)
NZ (1) NZ592168A (es)
PE (1) PE20120054A1 (es)
WO (1) WO2010041108A1 (es)
ZA (1) ZA201102497B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
JP5666743B2 (ja) 2011-08-27 2015-02-12 ウォックハート リミテッド １，６−ジアザビシクロ［３，２，１］オクタン−７−オン誘導体および細菌感染の処置におけるそれらの使用
AR090539A1 (es) 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
AU2014333436A1 (en) * 2013-10-11 2016-05-05 Wockhardt Limited Nitrogen containing compounds and their use
DK3221313T3 (en) 2014-11-17 2019-04-08 Entasis Therapeutics Ltd COMBINATION THERAPY FOR TREATING INFECTIONS WITH RESISTANT BACTERIA
BR112017020935A2 (pt) * 2015-04-03 2018-07-10 Mutabilis ?compostos, composição farmacêutica e conjunto?
KR102537340B1 (ko) 2016-09-16 2023-05-26 엔타시스 테라퓨틱스 리미티드 베타-락타마제 억제제 화합물
EP3301094A1 (en) * 2016-09-30 2018-04-04 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
MA48743A (fr) * 2017-05-08 2020-04-08 Entasis Therapeutics Inc Composés et méthodes de traitement d'infections bactériennes
WO2019093450A1 (ja) * 2017-11-10 2019-05-16 塩野義製薬株式会社 ジアザビシクロオクタン誘導体
CN118271319B (zh) * 2022-12-30 2025-02-28 成都四面体药物研究有限公司 一种β-内酰胺酶抑制剂含脲双环化合物、其制备方法及其用途
CN119998293A (zh) * 2023-08-08 2025-05-13 成都四面体药物研究有限公司 一种含脲三环的β-内酰胺酶抑制剂、其制备方法及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE423776T1 (de) * 1997-09-15 2009-03-15 Procter & Gamble Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
AU3089302A (en) * 2000-12-14 2002-06-24 Procter & Gamble Antimicrobial 2-pyridones, their compositions and uses
PL363323A1 (en) * 2000-12-14 2004-11-15 The Procter & Gamble Company Antimicrobial quinolones
FR2825705B1 (fr) 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2833596B1 (fr) * 2001-12-14 2005-02-18 Aventis Pharma Sa Procede de preparation de derives d'echinocandine
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2848210B1 (fr) * 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
US7232833B2 (en) * 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
FR2914923B1 (fr) * 2007-04-12 2013-06-14 Novexel Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens.

Also Published As

Publication number Publication date
EP2358722A1 (fr) 2011-08-24
CA2739776A1 (fr) 2010-04-15
US8148366B2 (en) 2012-04-03
WO2010041108A1 (fr) 2010-04-15
NZ592168A (en) 2013-03-28
CN102216307B (zh) 2015-02-25
US20100093784A1 (en) 2010-04-15
JP2012505195A (ja) 2012-03-01
ECSP11010962A (es) 2011-05-31
CN102216307A (zh) 2011-10-12
PE20120054A1 (es) 2012-01-26
EA201170546A1 (ru) 2011-12-30
FR2937034A1 (fr) 2010-04-16
IL212179A0 (en) 2011-06-30
CO6382121A2 (es) 2012-02-15
BRPI0919807A2 (pt) 2015-12-22
FR2937034B1 (fr) 2012-11-23
AU2009302149A1 (en) 2010-04-15
EP2853534A1 (fr) 2015-04-01
KR20110067140A (ko) 2011-06-21
MX2011003811A (es) 2011-07-29
ZA201102497B (en) 2011-12-28

Similar Documents

Publication Publication Date Title
CL2011000784A1 (es) Compuestos derivados de 7-h-pirazoli[3,4-e]-diasepina-6(5h)-ona sustituidos; procedimiento de preparacion; composicion farmaceutica, utiles como agentes antibacteriales.
CO6390082A2 (es) Compuestos organicos
CO6390080A2 (es) Compuestos organicos
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
HN2010001059A (es) Nuevo titulo modificado: compuestos derivados de pirimidina, un proceso para la preparacion de los mismos, una composicion farmaceutica que los comprenden y combinaciones de dichos compuestos con otros agentes.
CL2012000707A1 (es) Compuestos derivados de [5-(pirrolo[1,2-c][1.2.3]triazin-7-il)tetrahidrofuran-2-il]metanol; composición farmacéutica; y su uso para el tratamiento de la hepatitis c.
BRPI0813218A2 (pt) Composto, composição farmacêutica que o contém como princípio ativo e uso do composto.
MX2010004576A (es) Derivados de pirimidina novedosos.
CL2012000033A1 (es) Compuestos n-(3-(4as,7as)-2-amino-4a,5,7,7a-tetrahidro-4h-furo[3,4-d][1,3] tiazin-7a-il)-4- fluorofenilo) -5-fluoropiconilamida, inhibidor de bace; composicion farmaceutica que los comprende, uso del compuesto para el tratamiento de la enfermedad de alzheimer.
MY147949A (en) Hydrogenated benzo[c]thiophene derivatives as immunomodulators
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
MY154909A (en) Novel thiophene derivatives
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
ZA200807274B (en) Novel pyridine derivatives
CL2011000846A1 (es) Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
SV2008002969A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
UY31071A1 (es) Derivados heterociclicos sustituidos y su uso farmaceutico y composiciones
ECSP099394A (es) Derivados de quinuclidinol como antogonistas de receptores muscarínicos
TW200942524A (en) Novel aminomethyl benzene derivatives
CR10722A (es) Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintetasa quinasa 3
MX372721B (es) Ánalogos halogenados de agentes antifi-broticos.
CL2004001678A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica; y uso de los compuestos como agentes bacterianos.
CR9268A (es) Nuevo derivado de diazabiciclononeno
UY29370A1 (es) Derivados de tiazol, composiciones que lo contienen, procedimientos de preparación y aplicaciones
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.